View the latest news stories

Click on the news headline or 'Read more' button to view the full news story

 

 

28 June 2019

Goettingen, GER | Royston, UK – June 27, 2019: Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry today launched a new vessel for its ambr® 250 modular benchtop automated mini bioreactor system. The single-use vessel has been specially designed for therapeutic cell lines and offers the potential for accelerated process development of cell and gene therapy applications and scale-up into cGMP single-use bioreactors and bags. The new...

 

02 May 2019

- New design for improved clone selection as well as media and feed optimization in fed batch and perfusion mimic conditions. - System supports Cell & Gene therapy applications, including HEK293 for viral vector production, T-cells, iPSCs and other immune-derived cell lines. - Official launch at the ESACT Conference in Copenhagen (May 5–8, 2019). Goettingen, GER | Royston, UK – May 2, 2019: Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical...

 

20 April 2018

• New vessel for ambr® 250 ht system will enable cost-effective, scalable process development of vaccines in cell culture • Premieres at the BPI European Summit in Amsterdam Goettingen, GER – 20 April 2018: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of a new mini bioreactor vessel for its ambr® 250 high throughput (ht) system. This new vessel, which is designed for optimal growth of adherent...

 

14 March 2018

• Unique, single-use perfusion system offers a fast-track to intensified cell culture process development • Product innovation being unveiled at BPI West Conference, San Francisco, USA Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr® 250 high throughout (ht) perfusion, a new automated parallel bioreactor system. It has been specially designed for rapid cell culture perfusion process...

 

19 September 2017

Sartorius Stedim Biotech (SSB) is delighted to announce that Louise Carroll, a Commissioning Engineer at its Royston site has won an “Endeavour Award” for Higher Education from the Faculty of Science, IT and Engineering at Cambridge Regional College. This award, further endorses Sartorius in Royston as an excellent technology employer that values its staff and encourages them to achieve their full engineering potential. The “Endeavour Award” was presented to Louise in recognition...

 

06 September 2017

Leading industrial biotechnology company Ingenza has acquired a high performance benchtop bioreactor system to enable faster development of new fermentation processes. The Sartorius ambr® 250 modular system combines automated operation and monitoring with small-scale, single-use fermentation vessels, offering potential benefits across the business. This compact instrument is designed to fit seamlessly into laboratory fermentation workflows, helping to accelerate development timelines....

 

14 June 2017

Johnson Matthey (JM) and Sartorius Stedim Biotech (SSB) today announced they will be hosting an ‘Introduction to Children Challenging Industry (CCI)’ in Royston at 11am on Tuesday 11th July. The event is open to all science and technology companies in East Anglia and will give an insight into the CCI programme, designed to provide 9-11-year-old children with positive perceptions of science-based manufacturing and technology. The programme, which has been running in the North of...

 

05 June 2017

• Unique system offers collection of massive quantities of cell culture data • QbD studies in upstream processing more rapidly performed • On show for the first time at Cell Line Development & Engineering in San Diego Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced that the ambr® 15 automated micro bioreactor system combined with a Nova Biomedical (Nova) BioProfile® FLEX2 automated cell culture analyzer is on...

 

17 May 2017

Sartorius Stedim Biotech (SSB), a leading international supplier to the biopharmaceutical industry, today announced an agreement with Nova Biomedical (Nova), a well-known US manufacturer of cell culture analyzers, to integrate their BioProfile® FLEX2 into the ambr® multi-parallel bioreactor systems for automated, at-line cell culture analytics. SSB and Nova are collaborating to combine two highly innovative technologies. Both the BioProfile® FLEX2 analyzer and the parallel...

 

23 January 2017

Sartorius’ Royston site is pleased to announce that applications are now being invited for its award-winning Engineering Apprenticeship Scheme. The NVQ Level 3 Diploma qualification is being offered in partnership with Cambridge Regional College (CRC) and gives apprentices the opportunity to gain experience, skills and knowledge in different areas of their high-tech engineering business from Design through to Manufacturing and Commissioning. Sartorius’ Royston site, who have...

 

31 October 2016

Sartorius Stedim Biotech (SSB) today announced that it is co-presenting a new bioprocess webinar with Cobra Biologics, a leading international Contract Development and Manufacturing Organization (CDMO), on Tuesday 15th November. Two live events (at 09.00 GMT and 16.00 GMT) will detail how Cobra Biologics is using the ambr® 250 modular to accelerate process development and screening of microbial products and platform processes. During the live one-hour webinar, Dr Barney Zoro, ambr...

 

28 September 2016

Sartorius Stedim Biotech (SSB) today announced that it is co-presenting a new bioprocess webinar with WuXi Biologics, a premier Contract Discovery, Development and Manufacturing Organization, on Thursday 20th October. Two live events (at 09.00 GMT and 15.00 GMT) will include detail how WuXi Biologics is using ambr® micro and mini bioreactor platforms to accelerate bioprocess development of biologics in production scale single-use bioreactors. During the live one-hour webinar, Dr Barney...